The University of Wollongong Signs Collaboration with AMTZ for 3D Bioprinting Expertise in India

The University of Wollongong Signs Collaboration with AMTZ for 3D Bioprinting Expertise in India

September 18, 2019

The University of Wollongong has signed a strategic collaboration with Andhra Pradesh Medtech Zone in Visakhapatnam, India, bringing its expertise in 3D bioprinting techniques to India’s first integrated medical devices manufacturing zone.

Among many research initiatives to be taken up under the collaboration, one of the projects will be to develop a scan and printing package to produce 3D printed ears, while the main focus of the collaboration will be on biofabrication. This will be coupled with innovative programs to support widespread deployment of the technology in India and Australia.

Translational Research initiative for cellular Engineering and Printing of University of Wollongong will provide critical input into both research and training initiatives.

University of Wollongong Vice-Chancellor, Professor Paul Wellings, CBE; Distinguished Professor Gordon Wallace; UOW’s Global Brand Ambassador, Adam Gilchrist, AM; and Dr Jitendar Sharma, Managing Director & CEO of Andhra Pradesh Medtech Zone and Advisor to Government of Andhra Pradesh, India are the ones who took part in the signing ceremony.

 “As a research-intensive university with internationally renowned expertise in this field, UOW is very proud to be part of this exciting new precinct that will put India on the global map of high end medical equipment production and make health care products more affordable and accessible in India but across the world,” Professor Wellings said.

Representatives from Austrade and Australia’s Department of Foreign Affairs and Trade are some other members of the visiting delegations.

Source: University of Wollongong

Author : Meha Prasad

Tags :

Healthcare
x

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy and Cookie Policy. By continuing to use this site or closing this box, you consent to our use of cookies! Accept